
0:41
Dr. Charles Mok breaks down Daxify's claims: it lasts six months in only 47% of people, needs twice as many units as Botox, and costs more. He recommends aiming for four months as the better balance of dose and value.

Dr. Charles Mok breaks down Daxify's claims: it lasts six months in only 47% of people, needs twice as many units as Botox, and costs more. He recommends aiming for four months as the better balance of dose and value.
There's a new product out called Daxify. Now, the Daxify is billed as the six month toxic. Okay. There's a problem with that. So if you say your toxic lasts six months, you expect it's going to last six months. It does it 47% of people, okay. And you have to use twice as many units as you would at Botox or Xeomin. So now you use twice as many units for product that costs more to begin with. For something that only 47% of people less than half and will get a longer duration use twice as many use as Xeomid. Here you get an average of five or six months that they're toxic for almost everybody. So, so the there is a dose distribution or dose duration curve, but it's not linear. Typically, what we want the dose to last approximately four months because that's the best bang for your buck.

Functional Movement vs Traditional Physical Therapy #shorts #mobility #physicaltherapy

Knee Arthritis? It Might Not Be Your Knee #kneepain #jointpain #arthritis #shorts

Lifestyle vs Medication: A Smarter Approach to Heart Health #shorts #hearthealth

How to Build a Strong, Healthy Back for Longevity (Before Pain Starts) #muscle #shorts #longevity